Abstract As a major cardiac voltage-gated sodium channel isoform in the heart, the Nav1.5 channel is essential for cardiac action potential initiation and subsequent propagation throughout the heart. Mutations of Nav1.5 have been linked to a variety of cardiac diseases such as long QT syndrome (LQTs), Brugada syndrome, cardiac conduction defect, atrial fibrillation, and dilated cardiomyopathy. The mutagenesis approach and heterologous expression systems are most frequently used to study the function of this channel. This review focuses primarily on recent findings of Nav1.5 mutations associated with type 3 long QT syndrome (LQT3) in particular. Understanding the functional changes of the Nav1.5 mutation may offer critical insight into the mechanism of long QT3 syndrome. In addition, this review provides the updated information on the current progress of using various experimental model systems to study primarily the long QT3 syndrome.
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Structure and Physiologic Function of Voltage-Gated Sodium Channels
Voltage-gated sodium (Nav) channels initiate action potential depolarization and are responsible for propagating the action potential throughout the heart [42] . These channels are composed of a single pore-forming a subunit with a molecular weight of 33 to 36 kD that may interact with ancillary b subunits [7] . The a subunit consists of four structurally homologous transmembrane domains designated D1 to D4 [44] . Each domain is composed of six putative transmembrane segments named S1 to S6. The extracellular linker region between segments 5 and 6 within each domain joins together with other three linkers between segments 5 and 6, forming the channel pore referred to as the ''P loop'' or the ''P segment,'' which controls ion selectivity and permeation (Fig. 1) .
The site-directed mutagenesis approach helped to identify the functional regions on S4 of the sodium channel [47] . Positively charged residues such as arginine or lysine at every third position (with mostly nonpolar residues intervening between these basic residues) on S4 segments are voltage sensors, which can lead to fast activation of the sodium channel when the membrane potential is depolarized. The a subunit itself can form a functional channel that is able to conduct ions and perform the voltage-dependent gating process.
Upon activation, the channel is unable to open again due to the channel-gating process called ''inactivation.'' This process varies from milliseconds (steady-state fast inactivation) to a sustained time up to a few seconds (slow inactivation). Inactivation is the process that causes the termination of the current flow [19] .
Molecular biology and advanced biochemistry techniques allow us to know certain regions of the sodium channel responsible for channel fast inactivation. These regions are the isoleucine-phenylalanine-methionine (IFM) motif with three hydrophobic amino acids, Ile-Phe-Met [58] , in the segment between transmembrane domains 3 and 4 (D3, D4), the intracellular linker between S4 and S5 of D3 and D4, the P loop, and the C-terminal domain of the channel [15] .
As mentioned earlier, the sodium channel also consists of auxiliary b subunits. To date, four sodium channel b subunits (b 1 to b 4 ) have been identified. These four subunits can be divided into two groups. One group contains b 1 (encoded by SCN1B and located in brain neuronal tissue, skeletal muscle, and cardiac tissue [30] ) and b 3 (encoded by SCN3B and located primarily in neuronal tissue [35] ), whereas the other group contains b 2 and b 4 . In the amino acid sequence, b 1 and b 3 are very similar and noncovalently linked with a subunits [21, 35] . Studies indicate that the b subunit interacts with D1 and D4 of the a subunit [31] . Coexpression of the b 1 subunit with the a subunit modulates channel-gating kinetics [31] .
Coexpression of the b 1 subunit with the neuronal or skeletal muscle a subunit in Xenopus oocytes was shown to increase cell surface channel expression. Furthermore, channel inactivation and activation rates were both altered. The channel inactivation curve was shifted to more negative potentials when the b 1 subunit was coexpressed with the cardiac sodium channel a subunit [30, 37] . Lori Isom's group studied the expression of a and b subunits in heart tissue and identified the Nav1.1 a subunit, Nav1.5 a subunit, b 1 , and b 2 [12] . Other groups have indentified the existence of Nav1.1, Nav1.3, Nav1.6, and Nav1.5 in cardiomyocytes [28, 29] . Studies also have detected b 3 in the heart [12, 14, 35] . The developmental time course of b 2 subunit expression suggests that it is at detectable levels from postnatal day 15. Findings have shown that both Nav1.5 and Nav1.1 are coexpressed with b 1 and b 2 subunits [12] . In cardiomyocytes, it was shown that although the a subunit associates with both b 1 and b 2 subunits, only the b 1 subunit has a modulatory effect on the electrophysiologic properties of Nav1.5. The b 2 subunit seems to have no detectable effects on the electrophysiologic properties of cardiac sodium channels, suggesting that the effects of b 2 in the heart in vivo may involve cell adhesion and cytoskeletal communication rather than modulation of the channel-gating process [12] .
To date, there are nine subtypes of voltage-gated sodium channels, namely, Nav1.1 to Nav1.9, and they are encoded by different genes [16] . Nav1.1, Nav1.2, Nav1.3, Nav1.6, Nav1.7, Nav1.8, and Nav1.9 are found in neurons, whereas Nav1.1, Nav1.2, and Nav1.6 are found in the brain. Nav1.4 is found highly expressed in skeletal muscle. In cardiac tissue, the predominant form of the sodium channel is Nav1.5, which is encoded by the SCN5A gene. Mutations of this gene have been linked to many types of cardiac arrhythmia such as long QT3 syndrome, atrial fibrillation, sick sinus node syndrome, Brugada syndrome, conduction defect, and dilated cardiomyopathy [5, 6, 11, 33, 45, 51, 52] .
Cardiac Sodium Channel Nav1.5 Tissue Distribution
As mentioned earlier, the major cardiac sodium channel a subunit in the heart is Nav1.5 [58] . The a subunit is encoded by the SCN5A gene. Most mutations that affect the cardiac sodium channel are located on this gene. Cardiomyocytes also express neuronal Nav channel isoforms, such as Nav1.1, Nav1.3, and Nav1.6, but the locations of these channels are mainly located on T-tubules [29] . The Nav1.5 isoform, found at high levels, is the major sodium channel isoform in adult rat heart [42] .
The Nav1.5 isoform is detectable in embryonic skeletal muscle, neonatal skeletal muscle and denervated skeletal muscle [25] . However, it is not detectable in adult skeletal muscle. Like other types of voltage-gated sodium channels, these channels contain a principal a subunit and one or more auxiliary b subunits. The a subunit is the poreforming subunit, which can form a functional channel when expressed alone in the heterologous expression system. When expressed, this large a subunit accounts for the defining properties of voltage-gated sodium channels. It contains characteristic toxin-binding sites, the channel pore, gates, and voltage sensors. The tissue distribution of the cardiac sodium channel has been demonstrated by both immunohistochemistry and conventional reverse transcriptase-polymerase chain reaction (RT-PCR) experiments. Findings have shown that these channels are located not only on the cardiomyocyte surface but also on T-tubules. Later, it also was demonstrated that cardiac sodium channels are concentrated at the terminal of the intercalated discs [9, 29] , which separate adjacent cells and contain gap junctions responsible for propagating the cardiac action potential. The specific distribution of Nav1.5 compared with the neuronal forms of the sodium channel in the heart suggests that it may be crucial for initiation of the action potential, which propagates from one cell to the other within the heart. However, the specialized distribution pattern of neuronal forms of sodium channels within the heart suggests that they are responsible for conducting action potentials inside the myocyte to activate the contractile machinery [10] .
Function of Nav1.5 on Long QT3 Syndromes
In the patient population identified as carrying LQTs, about 50 % were associated with mutations on channels or associated proteins. Since the first identification of genetic mutations that cause LQTs in 1991, mutations have been discovered in 12 different genes. The classification of the inherited LQTs was based on the chronological order in which the location of the mutation was identified. In 1995, the first SCN5A mutation was identified by Wang et al. [52] as associated with type 3 LQTs (LQT3).
Sodium channel mutations account for about 7 % of the total identified LQTs-causing mutations. The typical electrocardiographic (ECG) study for LQT3 indicates the long ST-segment interval before the onset of a late prominent T-wave, which is the characteristic of the LQT3 phenotype. Mutations in the a subunit of the cardiac sodium channel have been identified and linked to a series of other cardiac diseases such as Brugada syndrome, sick sinus node disease, cardiac conduction defect, dilated cardiomyopathy, and atrial fibrillation [39, 45, 46, 48] .
The LQT3 disease-causing gene was mapped to 3p21-24 by Mark Keating's group using the ''candidate gene approach'' [24] . Three amino acid lysine, proline, and glutamine deletions (DKPQ) at positions 1,505 to 1,507 of the a subunit in affected members of two distinct families with an LQTs history were found by this group, and this triple amino acid deletion is the most extensively characterized. This three-amino-acid in-frame deletion (Lys-1505, Pro-1506, Gln-1507) was predicted to be in the cytoplasmic linker between D3 and D4. The presence of exactly identical deletions in two unrelated families with an LQT3 history provides strong evidence that a SCN5A mutation is the most likely cause of LQT3.
In 1995, Bennett et al. [4] reported biophysical properties of this mutant channel. They showed that fast inactivation of the mutant channel is delayed because time constants for current decay were decreased in the DKPQ mutant (WT: s fast = 1.47 ± 0.11 ms, s slow = 8.59 ± 0.71 ms; DKPQ: s fast = 0.98 ± 0.07 ms, s slow = 5.40 ± 0.55 ms, p \ 0.01; data are presented as means ± standard error of the mean) and not increased as was predicted. However, unlike WT channels, there is abnormal sustained sodium current (I sus ) in DKPQ-expressing cells. The I sus (*5 % of the peak inward current at -20 mV) was shown not to decay within a 200-ms depolarization pulse [50] . This sustained current, also called late I Na , was additionally found in a large number of other LQT3-related sodium channel mutations [2] . Single-channel recordings indicated that DKPQ channels present multiple intermittent reopenings, which induce an I sus or delayed inactivation. Besides phenotypical sodium channel changes, which are indicated by this first identified DKPQ sodium channel mutation, other gain-of-function electrophysiologic changes including leftward shift of the activation curve, increase of window current, faster recovery from inactivation, and ramp current are also identified as correlated with the LQT3 syndrome [3, 20] .
Voltage-gated sodium channels underscore the rapid depolarization phase in ventricular cardiomyocytes and also conduct a small portion of current during the plateau phase of the action potential [1] . Therefore, a subtle abnormality of the sodium channel function such as delayed sodium channel inactivation or altered voltage dependence of channel inactivation could delay the cardiac repolarization phase. As a consequence, sodium channel functional defects can cause a small increase in the net inward sodium current and lead to QT interval prolongation and arrhythmia.
Typically, the SCN5A mutations correlated with LQT3 are gain-of-function mutations (Table 1) . Studies have demonstrated that gain-of-function mutations disturb the delicate balance between outward and inward currents, which are involved in the plateau phase of the action potential repolarization process. In the presence of action potential duration (APD) prolongation, there is a propensity for cardiomyocytes to develop early after-depolarizations, which can trigger torsades de points (TdP). Under normal conditions, during the plateau phase, nearly 99 % of the channels become inactivated and transitioned into a nonconducting state, whereas the remaining channels stay in the open activated state, sustaining a small window current that contributes to the plateau phase. Therefore, mutations that disrupt the inactivation process dramatically enhance the window current and lead to the APD prolongation [4] .
Past Approaches Currently Used to Study MutationInduced LQTs Including LQT3 Syndrome

Heterologous Expression System
Early studies on the voltage-gated sodium channel were performed in vitro using Xenopus oocytes as a heterologous expression system [55, 56] . These studies offered detailed fundamental characterizations of the voltage-gated sodium channel.
Human embryonic kidney (HEK) cells such as HEK293 cells are the most frequently used to study functional changes after SCN5A mutations [3] . Other HEK cells such tSA cells and Chinese hamster ovary (CHO) cells are also used as heterologous expression systems [32, 40] . Together, these varieties of expression systems offer a platform for studying the physiologic function of the sodium channel and pathophysiologic changes after gene mutations. However, the advantage of these systems is limited because the cellular signaling component might be different from the cardiomyocyte.
Mouse Model of LQT3
With the development of the transgenic animal technique, experimental mouse models are emerging as a useful tool for studying the LQT3 syndrome in vivo ( Table 2) . Transgenic mouse models carrying DKPQ and N1325S mutants have been made [18, 38, 57] . In vivo studies from these mice have indicated the presence of a prolonged QT interval, spontaneous ventricular tachycardia, and ventricular fibrillation. In vitro electrophysiology studies have indicated that cardiomyocytes from these mice have prolonged APD, increased I sus , and early after-depolarizations [13, 41, 49] .
These animal models provide an opportunity to study the underlying mechanism of LQT3. However, the limitation of the mouse model must be taken into account because significant electrophysiologic differences exist between mouse and human hearts [36] . Based on this, data generated using mouse model must be interpreted with caution.
Computational Approach
To date, a number of studies have used the computational approach to simulate the action potential profile changes subsequent to Nav1.5 channel mutations and drug application [23, 53] . The predicted computational analysis method allows researchers to explore the effects of diseasecausing mutations on cellular electrical activity. One is beneficial not only from modeling of the action potential profile itself but also from pacing of the cell with a different frequency and getting to know cellular activity [13, 39, 40] WT/N1325S Intracellular region between S4-S5 of D3 of Nav1.5 Transgenic :Late I Na [51] WT/1798insD C-terminal domain Knock-in :Late I Na , ;I Na [42] changes resulting from gene mutation or drug application based on the computational approach. Therefore, mechanistic insights into mutations can be obtained. Although this approach is widely used, ultimate changes in the action potential profile still are hypothetical. Other approaches such as using primary myocytes indeed need to be explored.
Neonatal Cardiomyocyte Expression Model
Recently, neonatal mouse cardiomyocytes have been used as a mammalian expression system to study ion-channel mutations found in patients with LQTs [27] . In this study, fresh isolated cardiomyocytes from neonatal mice were transiently transfected with the cDNA encoding the channel of interest using the Amaxa Nucleofector Kit (Lonza Inc., Lonza Cologne AG, Köln, Germany). The advantage of using neonatal cardiomyocytes as an expression system is that these cells have essential signaling components, which may play a very crucial role in regulating ion channels. Although this approach has not been applied to study the sodium channel mutation that causes LQT3, it could be one of the future experimental approaches. Recently, we have extended our study of SCN5A mutations using neonatal rat cardiomyocytes, which express a mutant SCN5A cDNA. The mutation was previously identified in human patients. The ex vivo gene transfection method has been used, with transfection of the gene using the Amaxa Nucleofector Kit. Using this approach, we studied the functional effect of a mutation on intracellular loop 3 and found that this mutation not only causes a series of gain-of-function changes in electrophysiologic properties and the gating process but also leads to a significant prolongation of the APD (unpublished data). Spontaneous early after-depolarizations also were found (unpublished data). Although the exact copy number of the plasmids introduced into myocytes cannot be determined, this approach offers a new strategy for studying electrophysiologic properties of the cardiac sodium channel using primary cells.
Future Direction of Modeling Cardiac LQT3 Syndrome With Pluripotent Stem Cells
Itzhaki et al. [22] and Moretti et al. [34] established the most recent new paradigm for in vitro disease modeling of LQT1 and LQT2 syndromes. In their studies, induced pluoripotent stem cells (iPS cells) from patients experiencing the disease with characteristics of LQTs were differentiated into cardiomyocytes. This new advancement offers a new platform and strategy for mechanistically studying the channel mutation. In addition, it is useful for testing therapeutic compounds. In the future, iPS cell lines from LQT3 patients can be used for differentiation into cardiomyocytes, and the pathophysiologic changes caused by a specific mutation can be potentially explored. Therefore, mutation-specific and individualized therapy can be potentially established.
Conclusions
This review summarizes the current understanding of the sodium channel and focuses particularly on its physiologic and pathophysiologic functions in cardiac arrhythmia. Various approaches for studying the LQTs-related channel mutations have been discussed in this review. We have used a strategy to characterize the LQT3 syndrome diseasecausing SCN5A mutations in neonatal rat cardiomyocytes. Functional changes in the action potential profile such as APD prolongation and the onset of spontaneous early afterdepolarizations resulting from certain sodium channel mutations were identified. Therefore, our approach using neonatal rat cardiomyocytes to study the LQT3-related sodium channel mutations is a useful and effective strategy for analyzing the physiologic phenotypes of various sodium channel mutations.
